title: Transformed essential thrombocytosis with a JAK2 V617F mutation relapsing as JAK2 mutation-negative leukaemia after allogeneic stem cell transplantation.
authors.forename: W Y
authors.initials: WY
authors.lastname: Au
authors.forename: A
authors.initials: A
authors.lastname: Fung
authors.forename: K Y
authors.initials: KY
authors.lastname: Lam
authors.forename: A K
authors.initials: AK
authors.lastname: Lie
authors.forename: R
authors.initials: R
authors.lastname: Liang
authors.forename: Y L
authors.initials: YL
authors.lastname: Kwong
mesh_terms: D002471:Cell Transformation, Neoplastic; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D007938:Leukemia / Q000209:etiology*; D008875:Middle Aged; D020125:Mutation, Missense; D012008:Recurrence; D013920:Thrombocythemia, Essential / Q000150:complications* / Q000235:genetics* / Q000628:therapy; D014184:Transplantation, Homologous
chemical_list: C507924:JAK2 protein, human; D053614:Janus Kinase 2